Science-Savior, But Also Dangerous In The Hands of The Military Or Unstable Individuals

 

Beautiful But Dangerous 

 

Missile Launch


Mike Gomez Fishes in Southern Californiaís Castaic Lake While A Vapor Cloud, Created By The Launch Of A Minuteman Missile Ii, Sits Overhead Oct. 2. Launched From Vandenberg Airforce Base, The Unarmed Missile Was Destroyed By Another Missile Called The Kill Vehicle About 400 Miles North Of Kwajaliem Island.

UNITED STATES

Biological warfare
 
America the unready
N E W   Y O R K 
Biowarfare could be the worst terrorist threat of all 
 
  DOES America really face the possibility of a biological Armageddon? Since ABC News broadcast a television horror story in October-terrorists tossing bottles of anthrax spores on to the tracks of some unnamed American city's underground railway, releasing an invisible cloud of lethal bacteria that would kill 50,000 people within a week-nerves have been tingling even more sharply. The programme, ABC made clear, was pure fiction, like Orson Welles's apocalyptic radio tale of alien assault in 1938. Yet many viewers complained that the network was encouraging potential terrorists. Others accused it of unnecessary theatrics.
The secretary of defence, Bill Cohen, seems to take the matter seriously. He said recently that, if a biological attack did come, the contagion could spread horrifyingly: doctors would be able to offer little relief, hospitals might become warehouses for the dead and dying. "This is not hyperbole," Mr Cohen insisted. The head of the FBI, Louis Freeh, talking to the Senate last year, included biological weapons among the instruments of mass destruction that terrorist groups might well want to use.
Yet the head of Mr Freeh's domestic-terrorism unit, Robert Burnham, considers the risk of a biological attack to be relatively low (though he worries about a loophole in federal law that makes the possession of bioweapons like anthrax perfectly legal). And the sceptics point out that America's armed forces, understandably wanting more money to protect the country against such horrors, are unlikely to play down the danger.


One anti-sceptic is Donald Henderson, director of the Centre for Civilian Biodefence Studies at Johns Hopkins University, who believes that the threat of bioterrorism has increased in recent years. He dismisses the widely held view that the scientific expertise required to produce and disperse lethal organisms is within the reach of only the most sophisticated laboratories. "Recipes for making biological weapons are available on the Internet," he argues, "and even groups with modest finances and basic training in biology and engineering could develop an effective weapon at little cost."
The Japanese cult-group Aum Shinrikyo is best known for its 1995 sarin gas attack on the Tokyo subway system, but it is believed that it also planned to use biological weapons against American troops in Japan. Its arsenal is said to have included large amounts of nutrient media, botulinum toxin and anthrax cultures, besides drone aircraft equipped with spray tanks.
Dr Henderson says that two familiar microbes, smallpox and anthrax, are the most formidable threats. Anthrax, with a fatality rate of 80-90%, could knock out an entire city. Smallpox is also a killer of mind-boggling proportions: when the campaign to eradicate it began, in 1967, it was killing 2m people a year. And, unlike anthrax, smallpox is a highly communicable disease; it can spread like wildfire.


For the most part, smallpox was exterminated decades ago. That has a benefit and a disadvantage. The benefit is that "casual" terrorists would have great difficulty getting hold of it (officially, the only remaining stocks are held at one laboratory in America and one in Russia, though there are probably a few secret hoards in military laboratories around the world). The disadvantage is that the disease's disappearance means that there is not much vaccine around. The United States stopped vaccinating people in 1972, and about 90% of the population now lacks smallpox immunity. A major city could quickly be overrun by a disease in which one out of three people would die.


It would not take many such outbreaks to overwhelm the country's medical system. The Centre for Civilian Biodefence Studies says that, even if at first only 50 people were infected, the result could be a nationwide epidemic. Cities lack the isolation facilities needed to prevent the contagion spreading. In Washington, DC, for example, there are only about 100 hospital beds that could provide proper isolation of infected patients. If your spine is not yet tingling enough, reflect that the United States possesses nowhere near enough reserves of smallpox vaccine. It currently has about 15m doses to hand, but maybe only about half of these are usable. If more vaccine were needed, it would take up to a year to produce: at present no manufacturing capacity exists.
All this points to a serious gap in the country's preparedness to deal with a biological-weapons threat, despite the Clinton administration's efforts to increase anti-terrorism spending over the past two years. According to some doctors, the problem is partly one of priorities. Testifying to Congress recently, Tara O'Toole of the Johns Hopkins University School of Public Health said that anti-terrorism programmes have concentrated chiefly on the threat posed by conventional explosives or chemical weapons. Yet biological terrorism may not only be likelier than before; it is also far more threatening than either explosives or chemicals. Whereas the worst effects of a chemical or explosive attack are soon over, the devastation following a smallpox or anthrax outbreak can continue for weeks or months as the contagion goes on spreading.


An effective response would need lots of money. Yet for the current fiscal year the Department of Health and Human Services is requesting only $230m out of a total anti-terrorism budget of $10 billion-much less than President Clinton asked for when, 18 months ago, he announced a plan for a national response to terrorist incidents involving chemical or biological weapons.
Ms O'Toole says that hardly any American cities have practised their response to a biological attack. Even when bioterrorism scenarios are considered, she claims, hospital leaders and public-health experts are frequently excluded from the training sponsored by federal agencies. She wants the government to do much more to develop national pharmaceutical and vaccine stockpiles and to improve disease-surveillance systems. Michael Osterholm, a former Minnesota state epidemiologist, is even blunter. "We have a substantial national response to terrorism. The problem is they forgot to include a meaningful biological component."
A small military task force has now been set up, under Brigadier-General Bruce Lawlor, to help the civilians work out what to do if the worst happens. Yet perhaps even this does not address the real nightmare-that a genetically engineered pathogen might be set loose deliberately. Against that there would be no vaccine, and probably no handy antidote. And genetic technology is getting cheaper by the day.

 

 

Back To Altgenesis